Summary Analysis of Farmapiel®
Farmapiel® is a Mexican Pharmaceutical Laboratory that specializes in the development, manufacturing, and commercialization of Dermatological products. With over 25 years of experience, the company has been providing innovative and high-quality alternatives to the medical community, aiming to improve the health and living conditions of patients. Their broad product range covers therapeutic areas in Dermatology, including acne, photoprotection, dermatitis, depigmentation, hair loss, epidermal regeneration, cicatrization, and hyperhidrosis.
One of the key strengths of Farmapiel® lies in its state-of-the-art facilities and advanced technology, which allow the company to offer development and manufacturing services for various pharmaceutical forms, such as creams, ointments, gels, emulsions, solutions, suspensions, lotions, and capsules.
Founded in 1991, Farmapiel® has positioned itself in the Health Care and Pharmaceutical industries, maintaining its headquarters in Mexico.
Although specific details about their latest investment are not available, Farmapiel® presents a promising opportunity for venture capitalists interested in the pharmaceutical sector. This steady growth and commitment to quality make Farmapiel® an intriguing prospect for potential investors looking to support and benefit from advancements in dermatological healthcare.
There is no investment information
No recent news or press coverage available for Farmapiel®.
We care about your data, and we'd love to use cookies make your experience better.
